HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by El-Haschimi, K. Articles by Bjørbæk, C. Search for Related Content PubMed PubMed Citation Articles by El-Haschimi, K. Articles by Bjørbæk, C. Social Bookmarking                What's this?

Insulin Resistance and Lipodystrophy in Mice Lacking Ribosomal S6 Kinase 2

¹ Beth Israel Deaconess Medical Center, Boston, Massachusetts
² University Hospital Magdeburg, Magdeburg, Germany
³ Joslin Diabetes Center, Boston, Massachusetts

The p90 ribosomal S6 kinase 2 (RSK2) is a serine/threonine kinase with high expression levels in adipose tissue. Numerous in vitro studies show that RSK2 is activated by a broad number of cellular stimuli and suggest that RSK2 is involved in the regulation of a variety of cellular processes. However, the physiological role of RSK2 still remains elusive. We therefore generated rsk2 knockout (KO) mice to better understand the function of RSK2 in vivo. Birth weights of RSK2 KO mice are normal, but the body weight is reduced with age, as compared with wild-type littermates. We found that the difference in body weight was largely caused by a specific loss of white adipose tissue that is accompanied by reduced serum levels of the adipocyte-derived peptide, leptin. KO mice also have impaired glucose tolerance and elevated fasting insulin and glucose levels that are restored following administration of low amounts of leptin, which do not affect food intake. We conclude that RSK2 plays a novel and an important role in regulation of adipose mass in mice and speculate that the reduction in fat tissue may negatively affect insulin sensitivity, as observed in human lipodystrophy, through reduced levels of adipocyte-derived factors, such as leptin.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Kim, L.-W. Huang, K. J. Snow, V. Ablamunits, M. G. Hasham, T. H. Young, A. C. Paulk, J. E. Richardson, J. P. Affourtit, T. Shalom-Barak, et al. A mouse model of conditional lipodystrophy PNAS, October 16, 2007; 104(42): 16627 - 16632. [Abstract] [Full Text] [PDF]

				S. Gavi, L. M. Stuart, P. Kelly, M. M. Melendez, D. C. Mynarcik, M. C. Gelato, and M. A. McNurlan Retinol-Binding Protein 4 Is Associated with Insulin Resistance and Body Fat Distribution in Nonobese Subjects without Type 2 Diabetes J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1886 - 1890. [Abstract] [Full Text] [PDF]

				Y.-Y. Cho, Z. He, Y. Zhang, H. S. Choi, F. Zhu, B. Y. Choi, B. S. Kang, W.-Y. Ma, A. M. Bode, and Z. Dong The p53 Protein Is a Novel Substrate of Ribosomal S6 Kinase 2 and a Critical Intermediary for Ribosomal S6 Kinase 2 and Histone H3 Interaction Cancer Res., May 1, 2005; 65(9): 3596 - 3603. [Abstract] [Full Text] [PDF]

				B. A. Dummler, C. Hauge, J. Silber, H. G. Yntema, L. S. Kruse, B. Kofoed, B. A. Hemmings, D. R. Alessi, and M. Frodin Functional Characterization of Human RSK4, a New 90-kDa Ribosomal S6 Kinase, Reveals Constitutive Activation in Most Cell Types J. Biol. Chem., April 8, 2005; 280(14): 13304 - 13314. [Abstract] [Full Text] [PDF]